| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.07 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |